|
HS Code |
336868 |
| Product Name | (2-Fluorophenyl)Glycine |
| Cas Number | 107294-77-5 |
| Molecular Formula | C8H8FNO2 |
| Molecular Weight | 169.15 |
| Appearance | White to off-white solid |
| Melting Point | 112-116°C |
| Solubility | Soluble in water and polar organic solvents |
| Purity | Typically ≥98% |
| Smiles | C1=CC=C(C(=C1)F)C(C(=O)O)N |
| Inchi | InChI=1S/C8H8FNO2/c9-7-4-2-1-3-6(7)5(10)8(11)12/h1-5H,10H2,(H,11,12) |
| Synonyms | 2-Fluorophenylglycine; α-(2-Fluorophenyl)glycine |
| Storage Condition | Store at 2-8°C, protected from moisture |
As an accredited (2-Fluorophenyl)Glycine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a tightly sealed amber glass bottle containing 25 grams of (2-Fluorophenyl)Glycine, labeled with hazard and chemical information. |
| Shipping | (2-Fluorophenyl)glycine is shipped in tightly sealed containers, protected from moisture and light, and in compliance with chemical safety regulations. Transport is typically at ambient temperature unless otherwise specified, with clear labeling for handling as a laboratory chemical. Documentation includes safety data and hazard information for safe delivery and storage. |
| Storage | (2-Fluorophenyl)glycine should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers and acids. Store at room temperature and avoid sources of ignition or excessive heat. Proper storage will minimize decomposition and maintain chemical stability. |
Applications of (2-Fluorophenyl)Glycine in Industrial ManufacturingAs the direct manufacturer of (2-Fluorophenyl)Glycine, we supply this high-purity intermediate to specialized sectors that require precise control over synthesis and formulation. By meeting industry-grade specifications, our product supports complex downstream chemistries across multiple industrial scenarios. Detailed below are practical application segments based on actual market usage, with a focus on process parameters, regulatory frameworks, and finished output. 1. Pharmaceutical API Intermediate SynthesisPharmaceutical manufacturers utilize (2-Fluorophenyl)Glycine as a key building block in multi-step synthesis routes for several targeted small molecule drug candidates, including fluorinated analogs. Chemical engineers adjust molar ratios during amide coupling or Suzuki reactions, strictly following route-specific protocols. Final compound purification relies on HPLC and mass spectrometry validation to ensure downstream quality. Our audited production process supports large-batch delivery with traceability for clinical and commercial API manufacture. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient SynthesisAgrochemical producers source (2-Fluorophenyl)Glycine as a strategic intermediate when constructing phenylglycine-derived herbicides and insecticides. The fluorine moiety confers selective bioactivity, supporting the development of next-generation crop protection agents. Industrial chemists control concentration and input ratio to minimize by-product formation during condensation and cyclization reactions, maintaining tight contaminant profiles required for downstream formulation and environmental release approvals. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical Custom SynthesisContract and custom synthesis companies frequently request (2-Fluorophenyl)Glycine for the development of specialty molecules, particularly in high-performance materials and dye production. Chemists customize reaction scale and reagent ratio, optimizing for yield and selectivity under proprietary conditions. Production batches undergo rigorous in-process controls and final chromatographic purity verification to support applications with stringent end-user specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Peptide and Amino Acid Derivative ManufacturingSpecialty peptide producers incorporate (2-Fluorophenyl)Glycine into non-natural amino acid libraries for pharma and material science applications. Custom solid-phase or solution-phase synthesis leverages the molecule’s unique structure to alter peptide folding or receptor binding. Ratio and coupling conditions are tightly regulated to prevent racemization and maximize downstream biological activity. Batch records align with quality management systems to ensure dependable lot-to-lot reproducibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Chiral Building Block in Asymmetric SynthesisProducers of chiral catalysts and enantioselective reagents select (2-Fluorophenyl)Glycine as a precursor for manufacturing custom ligands. The chiral center and fluorinated aromatic ring impart selectivity for downstream asymmetric transformations in pharmaceutical and specialty chemical development. Ratio of the starting material is calculated relative to ligand scaffold and monitored throughout catalyst synthesis. Output batches undergo strict chiral purity analysis before shipping for catalytic applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (2-Fluorophenyl)Glycine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our team at the plant handles a steady demand for (2-Fluorophenyl)glycine. Over the years, we have observed the shift in medicinal chemistry toward the design of small molecules that maximize specificity and absorption. The addition of a fluorine atom to the aromatic ring of glycine increases metabolic stability and alters the molecule’s polarity. Rather than just supplying another glycine derivative, we have refined the production of this compound to give consistent, high-purity material.
Each lot of (2-Fluorophenyl)glycine leaves our facility with the clean, crystalline appearance we expect from a controlled synthesis. Seasoned bench chemists actively monitor the reactors, not only relying on instrumentation but also using years of accumulated hands-on experience. Handling of intermediates, crystallization steps, and final drying all receive critical attention during every batch. This care translates into a final amino acid with minimal impurities, meeting the tight specifications required in discovery labs and pilot projects.
In contrast to simple glycine, (2-Fluorophenyl)glycine’s aromatic character unlocks new options for peptide design and medicinal modification. Our own product development teams have watched its use spread from core peptide intermediates into enzyme inhibitor design, catalyst ligands, and as a chiral auxiliary in asymmetric synthesis. A standard glycine or phenylglycine does not offer this specific balance of lipophilicity and electronic influence that the ortho-fluorine imparts.
There is a reason why synthetic chemists request this building block for specific SAR explorations. Fluorination at the ortho position means that the phenyl ring no longer mimics simple phenylalanine or classic benzyl side chains. Instead, the electron-withdrawing effect helps to modulate hydrogen bonding and solubility within a molecule, which we have seen create downstream effects on compound behavior in biological assays. We have witnessed local researchers modify lead candidates by swapping in this amino acid and secure improved binding to protein targets, reflecting the subtle but valuable impact of the fluorine atom.
Many manufacturers treat specialty building blocks as commodity intermediates, relying on unmonitored, uncontrolled conditions. Our process design sits on the shoulders of chemists who built up knowledge across decades. We favor batchwise monitoring and incremental optimization. For (2-Fluorophenyl)glycine, this includes multi-stage purification and specific reactor profiles that maintain the integrity of the sensitive fluorinated ring.
Scaling up this type of aromatic amino acid presents unique challenges compared to simpler glycine derivatives. The ortho-fluorine affects both reactivity and the way the molecule crystallizes. Some contract manufacturers have failed to achieve reproducibility or scale, but our in-house synthesis and purification lines allow adjustments to mixing, temperature profile, and solvent recovery in real time. Operating with direct communication between process engineers and analytical chemists, we catch impurities or unwanted byproducts early, long before they reach later stages.
From direct observations, we know residual solvents or side-chain isomers can easily evade instruments if the operator only chases throughput. Daily experience has shown the importance of sight, smell, and texture for intermediary slurries. These “soft signals” supplement the more formal HPLC and NMR checks. Our team’s fingerprint on each batch appears most strongly in the repeatability and homogeneity of the final powder.
In research and pilot applications, chemists need more than just theoretical purity; they require real, dependable performance. One batch with traces of regioisomers or residual fluorinated byproducts can disrupt a peptide synthesis or bioassay, leading to lost weeks in project timelines. Early customers relied on our transparency around analytical results and our commitment to lot-to-lot consistency. We learned that research projects collapse not from visible errors, but from unseen inconsistencies in raw materials.
(2-Fluorophenyl)glycine features in demanding fields, including targeted drug design and advanced materials. With each cycle, our technical teams adjust for seasonal shifts in humidity, temperature, and even local electricity supply—minor factors that, over years, affect batch repeatability. Our experience reveals that the most sensitive applications unmask even tiny process variations. For example, oligopeptide synthesizers penalize materials with high moisture content or with micro-level spectral outliers, turning a pure-looking powder into an unusable lot. By controlling every step from precursor handling through to packaging, we maintain a level of confidence that partners count on when testing unproven lead compounds.
Working as a chemical manufacturer involves day-to-day problem solving, not theoretical exercise. During the scale-up of (2-Fluorophenyl)glycine, we faced recurrent foaming problems at one precipitation step, where released gases would carry product into the exhaust. Years of experimentation led to a redesign of agitation equipment and the introduction of controlled anti-foam additions, minimizing both loss and batch-to-batch inconsistency.
Another significant improvement stemmed from better control of acid-base cycles during isolation. Early processes yielded more colored material, with minute levels of decomposed aromatic fragments. Through targeted pH adjustments and crystallization temperature shifts, our operators restored purity, guided as much by observation as by analysis.
Whereas other vendors might accept a “mostly pure” assay, our standards are higher. Every gram of (2-Fluorophenyl)glycine must reflect hands-on craftsmanship. Each process change draws on root cause analysis and lessons from previous plant campaigns. Sharing these stories with industry peers has built our reputation for reliability in specialty amino acid supply.
We field requests for technical support that extend far beyond basic ordering. Researchers approach us with questions about reactivity profiles, solubility, and compatibility in SPPS workflows. Over time, we have compiled a growing set of case studies where (2-Fluorophenyl)glycine contributed to project success. Teams focused on fluorinated peptide probes, click-chemistry linkers, or new small-molecule inhibitors have provided feedback on downstream performance.
Practical feedback directly informs product improvements. For example, one customer documented minor rate reductions during automated peptide chain elongation when using lower-grade material from another source. Upon switching to our flagship grade, their workflow returned to expected cycle times. We ran mirror syntheses in our applications lab to confirm these findings and now incorporate advanced drying methods to lower residual water levels, maximizing coupling efficiency.
Because (2-Fluorophenyl)glycine rarely functions as the only building block in an experiment, its ability to blend into complex mixtures without introducing variables remains essential. This product attracts synthetic chemists not for its novelty but for its dependability in experimental sequences that leave little margin for error. Based on years of hands-on troubleshooting, we advise customers on dissolution procedures and pre-activation steps to prevent clumping or incomplete reactions, which can occur given the unique hydrogen bonding profile introduced by the ortho-fluorine.
Handling fluorinated intermediates calls for disciplined attention to safety protocols, especially during the earliest stages of synthesis. We have invested substantially in process containment infrastructure, advanced scrubbers, and continuous air monitoring. Our in-house training prioritizes not only compliance, but true understanding of exposure routes for each intermediate. By continually evaluating waste streams during purification, we seek to minimize the environmental footprint of our plant.
Crucially, our approach balances safety with resource efficiency. Recovered solvents are returned to larger plant streams where possible, with targeted analysis to prevent cross-contamination. Over time, this waste minimization model reduces both environmental load and input costs, without sacrificing product quality. We do not tout perfection, but real progress measured by the weight of safe, accountable output at the end of every campaign.
Our plant’s legacy is grounded in a culture of scientific rigor, not salesmanship. We invite partners and visiting scientists to tour our control room and see results firsthand. With (2-Fluorophenyl)glycine, every batch receives full NMR, HPLC, and mass spectrometry analysis, and we release full spectra to users who want to integrate raw data into their own compliance files.
We make no assumptions that internal protocols elsewhere duplicate ours. Several long-term collaborations grew out of labs that struggled to reproduce published findings using third-party material, only resolving discrepancies once they sourced from us directly. This experience solidified our belief that direct communication between supplier and researcher slows project attrition and speeds up innovation cycles. We value this trust as much as the technical transactions themselves.
We strengthen our offering through systematic feedback and industry partnership. Academic and pharmaceutical clients provide the real-world insight that helps us improve both process and product. For instance, a leading discovery group found that their standard coupling additives produced lower yields with the ortho-fluorinated glycine, prompting us to test alternate solvents, which ultimately provided a better route to high-yielding products for everyone involved.
Our technical staff regularly participates in external symposia and internal cross-trainings to ensure that state-of-the-art knowledge flows back into production. Instead of simply reacting to problems, we preempt common pitfalls by updating procedures in anticipation of the evolving needs of our customers. This attitude, reinforced by concrete results, allows us to remain a preferred partner for increasingly complex molecular projects.
We document and adapt to every unique usage scenario shared by customers, refining our recommendations based on these lived experiences. This system equips new researchers with practical tips gleaned from the field, saving time and reducing experimental dead ends. Efficient troubleshooting—rooted in both craft and technical evidence—keeps projects on track.
As specialty amino acids like (2-Fluorophenyl)glycine gain traction in emerging fields such as radiopharmaceuticals and advanced diagnostics, the requirements for purity, traceability, and delivery continue to tighten. Our ongoing investments in in-house analytics, cross-departmental QA programs, and technical cross-training ensure that we stay ahead of these rising expectations.
Looking ahead, we plan to expand capacity while maintaining a focus on batch reproducibility. We are developing automated monitoring protocols and additional purification steps, learning directly from production setbacks and customer feedback. Our team’s approach is never static. We remain open to process improvements and outside critiques—in fact, these are essential to refining every aspect of what we deliver.
(2-Fluorophenyl)glycine stands as both a technical achievement and a practical resource for pioneers in pharmaceutical and chemical research. We maintain this standard only through rigorous attention, direct engagement with users, and the accumulated wisdom of our entire production staff. Each kilogram produced carries the pride and diligence of our crew. We invite you to challenge our product with your next innovation, knowing that real progress in the lab depends on trusted collaborators at every stage.